Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study
Crossref DOI link: https://doi.org/10.1007/s13300-017-0230-2
Published Online: 2017-02-02
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Qin, Lei
Chen, Stephanie
Flood, Emuella
Shaunik, Alka
Romero, Beverly
de la Cruz, Marie
Alvarez, Cynthia
Grandy, Susan
Text and Data Mining valid from 2017-02-02
Article History
Received: 7 December 2016
First Online: 2 February 2017